EVH NYSE
Credit Risk of going bust: higher than 91% of companies Debt: 65.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.82 (down 82%), Evolent Health, Inc. would be worth roughly what it owes.
Total debt $970.4M against a stock market value of $509.5M.
Distance to default 1.48 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $483.2M (short-term plus half of long-term), stock volatility 80.2%; Altman Z'' -3.10. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Arlington, VA 22209
US
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McCarthy Daniel Jose | S-Sale | 65,892 | $5.00 | 2026-08-26 |
| Blackley Seth | A-Award | 446,102 | — | 2026-07-01 |
| Blackley Seth | F-InKind | 10,297 | $5.74 | 2026-07-01 |
| Weinberg Jonathan | A-Award | 43,055 | — | 2026-07-01 |
| Weinberg Jonathan | F-InKind | 2,650 | $5.74 | 2026-07-01 |